Jeffery W. Kelly
for elucidating the molecular basis of neurodegenerative and cardiac transthyretin diseases, and for developing tafamidis, a drug that slows their progression.
Affilié au moment de l'attribution du prix
La Jolla, États-Unis
La reconnaissance d'un travail ayant un impact durable
for elucidating the molecular basis of neurodegenerative and cardiac transthyretin diseases, and for developing tafamidis, a drug that slows their progression.
La Jolla, États-Unis